Načítá se...
What's New in SCLC? A Review
A few years ago the answer to the question in the title of this review would have been, “unfortunately not much” or even “nothing”, likely eliciting knowing nods of agreement from oncologists. For the last 3 decades, SCLC has been notorious for its lack of progress, as drug after drug, over 60 of th...
Uloženo v:
| Vydáno v: | Neoplasia |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Neoplasia Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5596356/ https://ncbi.nlm.nih.gov/pubmed/28888101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2017.07.007 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|